Wegovy 0.25 mg 1 Pre-filled Pen 1.5 ml – Weight Management Support
Wegovy 0.25 mg 1 Pre-filled Pen 1.5 ml is a medication designed to assist with weight management.
Product Description
Wegovy 0.25 mg 1 Pre-filled Pen 1.5 ml contains semaglutide, a GLP-1 receptor agonist, approved for chronic weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight-related health condition (e.g., hypertension, type 2 diabetes, or dyslipidemia). It is also beneficial in reducing the risk of major cardiovascular events (e.g., cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and obesity or overweight. This treatment should be used alongside a reduced-calorie diet and increased physical activity. Not recommended for patients under 18 years.
Product Contents
- Active ingredient: Semaglutide (0.25 mg per 0.5 ml dose).
- Each pre-filled pen contains 1.5 ml of solution, delivering an initial 0.25 mg dose.
- Inactive ingredients include disodium phosphate dihydrate, propylene glycol, phenol, and water for injection.
Indications for Use of Wegovy
Wegovy is approved as an adjunct to lifestyle modifications (reduced-calorie diet and increased physical activity) for:
- Adults with obesity (BMI ≥30 kg/m²).
- Adults with overweight (BMI ≥27 kg/m² to <30 kg/m²) with at least one weight-related health condition.
- Adults with established cardiovascular disease and obesity or overweight to reduce the risk of cardiovascular events.
Not recommended for patients under 18 years.
Product Benefits
- Supports weight loss and maintenance in eligible adults.
- Reduces cardiovascular disease risks in adults with heart disease, obesity, or overweight.
- Facilitates a gradual approach to weight management with the initial dose.
Instructions for Use
- Administer the injection subcutaneously once weekly in the abdomen, thigh, or upper arm.
- Can be taken with or without food at any time of day.
- Follow a gradual dose escalation schedule to minimize gastrointestinal side effects:
- Weeks 1-4: 0.25 mg
- Weeks 5-8: 0.5 mg
- Weeks 9-12: 1 mg
- Weeks 13-16: 1.7 mg
- From Week 17 onwards: 2.4 mg (maintenance dose)
- Rotate injection sites to prevent skin irritation or reactions.
What to Do If You Miss a Dose
- If you miss a dose, administer it within 5 days of the scheduled date.
- If more than 5 days have passed, skip the missed dose and resume your regular weekly schedule.
- You can change your injection day, provided there are at least 72 hours between doses.
Important Safety Information
Warning: Risk of Thyroid C-Cell Tumors
In rat studies, semaglutide caused thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in a dose- and duration-dependent manner. It is unknown whether Wegovy causes MTC in humans. Contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Monitor for symptoms such as a neck mass, difficulty swallowing, shortness of breath, or persistent hoarseness, and consult a healthcare provider if these occur.
Other Considerations
- May cause pancreatitis; seek immediate medical help for severe, persistent abdominal pain.
- Not recommended for patients with a history of medullary thyroid carcinoma or MEN 2.
- Possible side effects include nausea, diarrhea, vomiting, and constipation; consult a doctor if severe or persistent.
Warnings and Precautions
- Do not use if you have a hypersensitivity to semaglutide or any inactive ingredients.
- Consult a healthcare provider if you have a history of pancreatitis, gallbladder disease, or kidney issues.
- Avoid use during pregnancy or breastfeeding; discontinue at least 2 months before planning a pregnancy.
Product Details
- Brand: Novo Nordisk
- Size: 1.5 ml
- Category: Prescription medication for weight management
- Usage: Weekly subcutaneous injection
Storage Instructions
- Store in the refrigerator at 2–8°C.
- Do not freeze under any circumstances.
- Pre-filled pens can be stored at room temperature (below 30°C) for up to 28 days.
- FlexTouch pens can be used for up to 6 weeks after first use, whether at room temperature or in the refrigerator.
Frequently Asked Questions
Who is it suitable for?
For adults with obesity or overweight with related health conditions; not recommended for those under 18. Consult a doctor to determine eligibility.
How should it be stored?
In the refrigerator (2-8°C); pre-filled pens can be stored at room temperature for up to 28 days, while FlexTouch pens can be used for 6 weeks after first use.
What are the possible side effects?
May include nausea or diarrhea; contact a doctor if severe or persistent.
